Overview

Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia

Status:
Completed
Trial end date:
2019-03-31
Target enrollment:
Participant gender:
Summary
Identified the efficacy of Antroquinonol (Hocena 50mg) in triglyceride, lipid-lowering and fatty liver.
Phase:
Phase 2
Details
Lead Sponsor:
Golden Biotechnology Corporation
Treatments:
Ubiquinone